Ω-Loop mutations control dynamics of the active site by modulating the hydrogen-bonding network in PDC-3 β-lactamase

  1. UCL School of Pharmacy, London, United Kingdom
  2. Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, United States
  3. Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, United States
  4. Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, United States
  5. Clinician Scientist Investigator, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, United States
  6. Departments of Pharmacology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, United States
  7. CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland, Cleveland, United States
  8. University of Tabuk (PFSCBR), Tabuk, Saudi Arabia
  9. UCL Centre for Advanced Research Computing, London, United Kingdom

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Toby Allen
    RMIT University, Melbourne, Australia
  • Senior Editor
    Volker Dötsch
    Goethe University Frankfurt, Frankfurt am Main, Germany

Reviewer #1 (Public review):

Summary:

This manuscript uses adaptive sampling simulations to understand the impact of mutations on the specificity of the enzyme PDC-3 β-lactamase. The authors argue that mutations in the Ω-loop can expand the active site to accommodate larger substrates.

Strengths:

The authors simulate an array of variants and perform numerous analyses to support their conclusions.

The use of constant pH simulations to connect structural differences with likely functional outcomes is a strength.

Weaknesses:

I would like to have seen more error bars on quantities reported (e.g., % populations reported in the text and Table 1).

Reviewer #1 (Public review):

Summary:

This manuscript uses adaptive sampling simulations to understand the impact of mutations on the specificity of the enzyme PDC-3 β-lactamase. The authors argue that mutations in the Ω-loop can expand the active site to accommodate larger substrates.

Strengths:

The authors simulate an array of variants and perform numerous analyses to support their conclusions.

The use of constant pH simulations to connect structural differences with likely functional outcomes is a strength.

Weaknesses:

I would like to have seen more error bars on quantities reported (e.g., % populations reported in the text and Table 1).

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation